DIARRHEA PREVENTION AND PROPHYLAXIS WITH CROFELEMER IN HER2 POSITIVE BREAST CANCER PATIENTS RECEIVING TRASTUZUMAB, PERTUZUMAB, AND DOCETAXEL OR PACLITAXEL WITH OR WITHOUT CARBOPLATIN

Type of Cancer
Breast Oncology

Site
Hackensack

Sponsor
Georgetown

Protocol Number
Georgetown2015-0547 HALT-D

To Learn More Call
(201)-510-0950